What is the latest price of mavacamten in 2025
Mavacamten (mavacamten) is a drug used to treat adult patients with symptomatic obstructive hypertrophic cardiomyopathy. It is a cardiac myosin inhibitor. Its main mechanism of action is to reduce the interaction between actin and myosin, thereby reducing the intensity of cardiac contraction and reducing the burden on the heart.
The drug comes in oral capsule form and is usually recommended to be taken once a day with or without food, preferably at a fixed time. Patients should strictly follow the directions on the prescription label and consult their doctor or pharmacist when in doubt. When taking, swallow the capsule whole and do not cut, chew or crush the capsule.
Initially, the doctor may start with a low dose and gradually adjust the dose based on the patient's response to the drug to ensure safety and effectiveness. It is important to note that although Mavacartide can control symptoms, it does not cure obstructive hypertrophic cardiomyopathy. Therefore, the drug must be continued even if the patient feels well. Any decision to discontinue medication should be made in consultation with a physician to ensure the patient's safety and health.
MavakataiThe original drug has been launched in China and has been included in medical insurance. Common specifications include2.5mg*14 tablets*2 tablets, 5mg*14 tablets*2 tablets, 10mg*14 tablets*2 tablets, 15mg*14 tablets*2 tablets, etc. However, due to its short time on the market, its price is not yet clear. The original versions of Mavaketai marketed overseas include the European version and the American version. The American version may sell for about 60,000 yuan per box of 2.5mg specification, and the European version of 5mg may sell for about 20,000 yuan per box (the price may fluctuate due to exchange rates). At the same time, there are also generic versions of Mavaceta sold overseas. The drug ingredients are basically the same as those of the original drug. The price per box may be around RMB 1,050 (the price may fluctuate due to exchange rates).
Reference materials:https://medlineplus.gov/druginfo/meds/a622047.html
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)